Tumor-Induced Local and Systemic Impact on Blood Vessel Function
Endothelial dysfunction plays a role in several processes that contribute to cancer-associated mortality. The vessel wall serves as a barrier for metastatic tumor cells, and the integrity and activation status of the endothelium serves as an important defense mechanism against metastasis. In additio...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2015/418290 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832566784501219328 |
|---|---|
| author | J. Cedervall A. Dimberg A-K. Olsson |
| author_facet | J. Cedervall A. Dimberg A-K. Olsson |
| author_sort | J. Cedervall |
| collection | DOAJ |
| description | Endothelial dysfunction plays a role in several processes that contribute to cancer-associated mortality. The vessel wall serves as a barrier for metastatic tumor cells, and the integrity and activation status of the endothelium serves as an important defense mechanism against metastasis. In addition, leukocytes, such as cytotoxic T-cells, have to travel across the vessel wall to enter the tumor tissue where they contribute to killing of cancer cells. Tumor cells can alter the characteristics of the endothelium by recruitment of leukocytes such as neutrophils and macrophages, which further stimulate inflammation and promote tumorigenesis. Recent findings also suggest that leukocyte-mediated effects on vascular function are not limited to the primary tumor or tissues that represent metastatic sites. Peripheral organs, such as kidney and heart, also display impaired vascular function in tumor-bearing individuals, potentially contributing to organ failure. Here, we discuss how vascular function is altered in malignant tissue and distant organs in individuals with cancer and how leukocytes function as potent mediators of these tumor-induced effects. |
| format | Article |
| id | doaj-art-c92a2354f44947a4b202fc058687a7bb |
| institution | Kabale University |
| issn | 0962-9351 1466-1861 |
| language | English |
| publishDate | 2015-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Mediators of Inflammation |
| spelling | doaj-art-c92a2354f44947a4b202fc058687a7bb2025-02-03T01:03:20ZengWileyMediators of Inflammation0962-93511466-18612015-01-01201510.1155/2015/418290418290Tumor-Induced Local and Systemic Impact on Blood Vessel FunctionJ. Cedervall0A. Dimberg1A-K. Olsson2Department of Medical Biochemistry and Microbiology, Science for Life Laboratory, Biomedical Center, Uppsala University, P.O. Box 582, 75123 Uppsala, SwedenDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, 75185 Uppsala, SwedenDepartment of Medical Biochemistry and Microbiology, Science for Life Laboratory, Biomedical Center, Uppsala University, P.O. Box 582, 75123 Uppsala, SwedenEndothelial dysfunction plays a role in several processes that contribute to cancer-associated mortality. The vessel wall serves as a barrier for metastatic tumor cells, and the integrity and activation status of the endothelium serves as an important defense mechanism against metastasis. In addition, leukocytes, such as cytotoxic T-cells, have to travel across the vessel wall to enter the tumor tissue where they contribute to killing of cancer cells. Tumor cells can alter the characteristics of the endothelium by recruitment of leukocytes such as neutrophils and macrophages, which further stimulate inflammation and promote tumorigenesis. Recent findings also suggest that leukocyte-mediated effects on vascular function are not limited to the primary tumor or tissues that represent metastatic sites. Peripheral organs, such as kidney and heart, also display impaired vascular function in tumor-bearing individuals, potentially contributing to organ failure. Here, we discuss how vascular function is altered in malignant tissue and distant organs in individuals with cancer and how leukocytes function as potent mediators of these tumor-induced effects.http://dx.doi.org/10.1155/2015/418290 |
| spellingShingle | J. Cedervall A. Dimberg A-K. Olsson Tumor-Induced Local and Systemic Impact on Blood Vessel Function Mediators of Inflammation |
| title | Tumor-Induced Local and Systemic Impact on Blood Vessel Function |
| title_full | Tumor-Induced Local and Systemic Impact on Blood Vessel Function |
| title_fullStr | Tumor-Induced Local and Systemic Impact on Blood Vessel Function |
| title_full_unstemmed | Tumor-Induced Local and Systemic Impact on Blood Vessel Function |
| title_short | Tumor-Induced Local and Systemic Impact on Blood Vessel Function |
| title_sort | tumor induced local and systemic impact on blood vessel function |
| url | http://dx.doi.org/10.1155/2015/418290 |
| work_keys_str_mv | AT jcedervall tumorinducedlocalandsystemicimpactonbloodvesselfunction AT adimberg tumorinducedlocalandsystemicimpactonbloodvesselfunction AT akolsson tumorinducedlocalandsystemicimpactonbloodvesselfunction |